Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 36 of 36 publications.

Darden CM, Price MA, Kaye JA, Sherif BN, Marion S, Tzivelekis S, Garcia J, Chandler D. Same-day administration of pegfilgrastim following myelosuppressive chemotherapy: practices and rationale. Blood. 2015 Dec 3;126(23):5585. doi: 10.1182/blood.V126.23.5585.5585

Schwab PE, MacLean E, Chioda M, Moll K, Pasquale M, Mardekian J, Futch T. NSCLC observations combining medical charts and administrative claims data. Poster presented at the 2015 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5, 2015. Boston, MA. [abstract] Mol Tar Can Ther. 2015 Dec 1; 14(12 S2).

Balp MM, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Maurer M, Koenders J, Knulst AC, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Tian H, Elberink JN. Work productivity and activity impairment among chronic spontaneous/idiopathic urticaria patients: results from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Tian H, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Koenders J, Knulst AC, Elberink JN, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Balp MM, Maurer M. Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients- findings from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Silvia S, Hollis K, Wooddell MJ, Hogue S, White MV. The Epipen4schools® survey: prevalence and triggers of anaphylactic events in large US school districts. Presented at the 2015 ACAAI Conference; November 2015. San Antonio, TX.

White MV, Silvia S, Hollis KA, Wooddell M, Hogue SL. Characteristics and treatment of anaphylactic events in a US school setting: results from the EPIPEN4SCHOOLS® program survey. Poster presented at the American Academy of Pediatrics 2015; October 24, 2015. Washington, DC. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 CSACI Annual Scientific Meeting; October 24, 2015. Vancouver, Canada. Previously presented at the 2015 Eastern Allergy Conference.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® program pilot survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 XXIV World Allergy Congress (WAC); October 16, 2015. Seoul, Korea.

Raspa M, Sacco PN, Edwards AM, Bishop E, Wylie AC, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 2nd International Conference on FMR1 Premutation: Basic Mechanisms and Clinical Involvement; October 2015. Barcelona, Spain. Previously presented at the 48th Annual Gatlinburg Conference.

Weller K, Grattan C, Abuzakouk M, Berard F, Sussman G, Lynde C, Canonica GW, Knulst A, Ortiz De Frutos J, Nakonechna A, Gimenez-Arnau A, Oude Elberink JNG, Balp MM, Khalil S, Tian H, Hollis K, Sweeney C, Radder C, McBride D, Maurer M. Patient profile from the first international burden of illness study in inadequately controlled chronic spontaneous urticaria: ASSURE-CSU. Poster presented at the 24th European Academy of Dermatology and Venereology (EADV) Congress; October 2015. Copenhagen, Denmark.

Sheer R, Schwab PE, Noyes Essex M, Cappelleri JC, Reiners A, Bobula J, Pasquale M. Management due to sprains, strains and contusions in the Medicare population. Poster presented at the 2015 PAIN Week; September 8, 2015. Las Vegas, NV.

Sheer R, Schwab P, Essex MN, Cappelleri J, Reiners A, Bobula J, Pasquale M. Acute pain management due to sprains, strains and contusions in the medicare population. Poster presented at the PAINWeek 2015; 2015. Las Vegas, NV. [abstract] Postgrad Med. 2015 Sep 4; 127(S1):S86. doi: https://doi.org/10.1080/00325481.2015.1086533

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Differences in anaphylaxis-related risks by school grade level: findings from the EpiPen4Schools® survey. Poster presented at the 2015 ASCIA Conference; September 2015. Adelaide, Australia. [abstract] Intern Med J. 2015 Sep 3; 45(Suppl 4):3. doi: 10.1111/imj.12869

Vekeman F, Gauthier-Loiselle M, Faust E, Lefebvre P, Lahoz R, Duh MS, Sacco P. Patient and caregiver burden associated with fragile x syndrome in the United States. Am J Intellect Dev Disabil. 2015 Sep;120(5):444-59. doi: 10.1352/1944-7558-120.5.444

Sussman G, Lynde C, Zanganeh S, Lacuesta G, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Sweeney CT, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: an analysis of the diagnosis and treatment of patients with antihistamine-refractory CSU. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada. [abstract] Clin Transl Allergy. 2015 Aug 17; 5(29):1-7. doi: 10.1186/s13601-015-0072-9

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz De Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 17;17(5):29.

White MV, Goss D, Silvia S, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Goss D, Wooddell M, Hogue S, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools® survey. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Sussman G, Lynde C, Kanani A, Hebert J, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: redefining our understanding of the clinical characteristics of patients with CSU/CIU refractory to H1- antihistamines. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Grattan C, Lynde C, Abuzakouk M, Nakonechna A, Chiva-Razavi S, Halliday A, Chambenoit O, Hollis KA, McBride DW, Radder CN, Tian H, Balp MM. ASSURE-CSU preliminary UK and Canadian results: a characterisation of angioedema in patients with refractory CIU/CSU from the UK and Canada. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Nakonechna A, Lynde C, Grattan C, Halliday A, Chiva-Razavi S, Hollis KA, Balp MM. Impact of chronic idiopathic/ spontaneous urticaria on health related quality of life: aSSURE-CSU study results from Canada and the UK. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Grattan C, Balp MM, Halliday A, Abouzakouk M, Hollis KA, McBride DW, Westlund RE, Wolin DL, Tian H, Alexopoulos ST, Nakonechna A. ASSURE-CSU preliminary UK results: assessing the impact of CSU on absence from work and work productivity. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 Eastern Allergy Conference; May 28, 2015. Palm Beach, FL.

Sussman G, Lee J, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R, Tian H, Balp MM. ASSURE-CSU Canadian results: assessing the impact of chronic spontaneous/idiopathic urticaria on work productivity and indirect costs. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Sussman G, Waserman S, Keith P, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R. ASSURE-CSU Canadian results: assessing health utility in chronic spontaneous/idiopathic urticaria using the EQ-5D. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Associations between comorbidities and hospitalizations among patients with chronic obstructive pulmonary disease (COPD). Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Association between nonadherence to chronic obstructive pulmonary disease (COPD) maintenance medications and medications for other chronic conditions. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Liu W, Schwab PE, Lane D. Analysis of oral anti-diabetes medication splitting patterns in Medicare Advantage Prescription Drug (MAPD) plans population. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Rosen J, Lane D, Schwab PE. Comparison of telephonic vs. face-to-face comprehensive medication reviews in COPD patients. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Raspa M, Sacco PN, Edwards AM, Bishop E, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 48th Annual Gatlinburg Conference; April 2015. New Orleans, LA.

Sussman G, Lynde CW, Chiva-Razavi S, Chambenoit O, Hollis K, Westlund RE, Balp MM. Canadian sub-analysis of the ASSURE-CSU study: demographic characteristics and health related quality of life in patients with chronic idiopathic urticaria. Poster presented at the American Academy of Dermatology Annual Meeting; March 21, 2015. San Francisco, CA.

Sussman G, Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis K, McBride D, Balp MM, Berard F, Gimenez-Arnau AM, Frutos JO, Canonica GW, Knulst AC, Grattan C. Assessment of economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: study design of the first observational study, ASSURE-CSU. Poster presented at the American Academy of Dermatology Annual Meeting; March 20, 2015.

Wooddell M, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Hogue SL, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools survey. Poster presented at the 2015 AAAAI Annual Meeting; February 20, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(2):AB212.

Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.

White MV, Goss D, Hollis K, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 15, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(Suppl 2):AB212.

White MV, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue SL. EpiPen4Schools survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015; 135:AB212.